SCHEMBL3310876

SCHEMBL3310876

O=C(O)C(O)=CC(=O)c1ccc(-c2ccc(F)cc2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.54
KDM4E B2RXH2 3/20 0.54
NPC1 O15118 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 1/20 0.49
ESRRG P62508 4/20 0.48
PTPN2 P17706 1/20 0.48
PTPN11 Q06124 1/20 0.48
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
HDAC6 Q9UBN7 3/20 0.42
HDAC1 Q13547 3/20 0.42
TP53 P04637 2/20 0.42
GAA P10253 1/20 0.42
HSD17B1 P14061 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3310867 1.00 RAB9A (0.54) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3310871 1.00 RAB9A (0.54) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3309246 0.86 ESRRG (0.51) RAB9AMEN1KMT2APOLBESRRG
SCHEMBL3309252 0.86 ESRRG (0.51) RAB9AMEN1KMT2APOLBESRRG
SCHEMBL3309254 0.86 ESRRG (0.51) RAB9AMEN1KMT2APOLBESRRG
SCHEMBL4675315 0.86 RAB9A (0.57) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3310978 0.85 IKBKB (0.58) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3310980 0.85 IKBKB (0.58) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3310023 0.85 RAB9A (0.45) RAB9AKDM4ENPC1ALDH1A1HPGD
SCHEMBL3310036 0.85 RAB9A (0.45) RAB9AKDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 RAB9A 3609/4885KDM4E 1397/4885NPC1 2680/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 RAB9A 3609/4885KDM4E 1397/4885NPC1 2680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.